Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-002956
Filing Date
2023-02-21
Accepted
2023-02-21 19:05:11
Documents
1
Period of Report
2023-02-16

Document Format Files

Seq Description Document Type Size
1 form4-02222023_120249.html 4  
1 form4-02222023_120249.xml 4 11689
  Complete submission text file 0001415889-23-002956.txt   13219
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121
Business Address
LaBarre Michael J. (Reporting) CIK: 0001507174 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32335 | Film No.: 23650051